FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

FDA D.I.S.C.O. Burst Edition: FDA approval of Keytruda (pembrolizumab) for unresectable advanced or metastatic malignant pleural mesothelioma


Episode Artwork
1.0x
0% played 00:00 00:00
Nov 14 2024 3 mins   3
Other Episodes
Listen to a soundcast of the 9.17.2024 FDA approval of Keytruda (pembrolizumab) for unresectable advanced or metastatic malignant pleural mesothelioma.
Download episode Share
Copy URL



Listen on Podcast Addict
Subscribe on Podcast Addict